Multi-centre Peer Support Program in Type 2 Diabetes Patients in Hong Kong
Launched by CHINESE UNIVERSITY OF HONG KONG · Jun 26, 2015
Trial Information
Current as of June 03, 2025
Unknown status
Keywords
ClinConnect Summary
Aim of the Study:
1. To evaluate the impact of peer support program on various clinical, psycho-behavioral outcomes and health utilization outcomes in Hong Kong Chinese with type 2 diabetes
2. To evaluate the feasibility of a peer support program in Hong Kong
3. To evaluate the sustainability of a peer support program in Hong Kong
Duration of the program = 12 months
Indicators and targets:
* Number of peer supporters recruited: 12
* Number of peers recruited = 50
* Number of peer supporter training sessions = 2
* Number of reunion sessions for peer supporters with the investigators = 4
...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Type 2 diabetes
- • 2. Age between 18-75 years inclusive
- • 3. Chinese ethnicity
- • 4. High risk patients for poor diabetes control based on the self-administered questionnaire designed by the study team
- Exclusion Criteria:
- Exclusion criteria for peer supporters:
- • 1. Failure to have 100% attendance rate in the peer supporters training program
- • 2. Inadequate knowledge about diabetes after training program as judged by study investigators
- Exclusion criteria for the peers:
- • 1. No access to telephone
- • 2. Unable to speak Cantonese
- • 3. Unable to understand the scope of the project
- • 4. Serious mental or physical disability that prevents one from meeting and communicating regularly with peer supporter
- • 5. Serious medical illness with expected life expectancy \< 1 years such as terminal cancer
- • 6. Participation in any diabetes quality improvement program in the past 2 years such as peer support program, Joint Asia Diabetes Evaluation Program
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Rebecca Yee-Man Wong, BSc (Nurs)
Principal Investigator
HKIDO, CUHK
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials